Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.
Publication
, Journal Article
Menter, A; Strober, BE; Kaplan, DH; Kivelevitch, D; Prater, EF; Stoff, B; Armstrong, AW; Connor, C; Cordoro, KM; Davis, DMR; Elewski, BE ...
Published in: J Am Acad Dermatol
April 2019
Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations based on the available evidence. The treatment of psoriasis with biologic agents will be reviewed, emphasizing treatment recommendations and the role of the dermatologist in monitoring and educating patients regarding benefits as well as associated risks.
Duke Scholars
Published In
J Am Acad Dermatol
DOI
EISSN
1097-6787
Publication Date
April 2019
Volume
80
Issue
4
Start / End Page
1029 / 1072
Location
United States
Related Subject Headings
- Ustekinumab
- Pyrroles
- Pyrimidines
- Psoriasis
- Piperidines
- Infliximab
- Humans
- Evidence-Based Medicine
- Etanercept
- Drug Therapy, Combination
Citation
APA
Chicago
ICMJE
MLA
NLM
Menter, A., Strober, B. E., Kaplan, D. H., Kivelevitch, D., Prater, E. F., Stoff, B., … Elmets, C. A. (2019). Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol, 80(4), 1029–1072. https://doi.org/10.1016/j.jaad.2018.11.057
Menter, Alan, Bruce E. Strober, Daniel H. Kaplan, Dario Kivelevitch, Elizabeth Farley Prater, Benjamin Stoff, April W. Armstrong, et al. “Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.” J Am Acad Dermatol 80, no. 4 (April 2019): 1029–72. https://doi.org/10.1016/j.jaad.2018.11.057.
Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019 Apr;80(4):1029–72.
Menter, Alan, et al. “Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.” J Am Acad Dermatol, vol. 80, no. 4, Apr. 2019, pp. 1029–72. Pubmed, doi:10.1016/j.jaad.2018.11.057.
Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kavanaugh A, Kiselica M, Korman NJ, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Rupani RN, Siegel M, Wong EB, Wu JJ, Hariharan V, Elmets CA. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019 Apr;80(4):1029–1072.
Published In
J Am Acad Dermatol
DOI
EISSN
1097-6787
Publication Date
April 2019
Volume
80
Issue
4
Start / End Page
1029 / 1072
Location
United States
Related Subject Headings
- Ustekinumab
- Pyrroles
- Pyrimidines
- Psoriasis
- Piperidines
- Infliximab
- Humans
- Evidence-Based Medicine
- Etanercept
- Drug Therapy, Combination